XML 242 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income including non-controlling interests $ 722,146 $ 1,480,904
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 431,131 227,856
Gain on sale of assets (3,739) (521,495)
Impairment 28,964 1,073
Deferred income taxes 176,678 66,668
Net (gain) loss on derivative instruments (11,247) 128,766
Net gain from investment in unconsolidated affiliate (21,421) (38,977)
Equity-based compensation expenses 37,260 40,351
Deferred financing costs amortization and other 1,072 1,241
Working capital and other changes:    
Change in accounts receivable, net (258,175) (13,007)
Change in inventory (4,945) 2,199
Change in prepaid expenses 430 7,708
Change in accounts payable, interest payable and accrued liabilities 135,880 57,581
Change in other assets and liabilities, net 42,483 4,766
Net cash provided by operating activities 1,276,517 1,445,634
Cash flows from investing activities:    
Capital expenditures (642,584) (303,140)
Acquisitions, net of cash acquired (361,609) (148,363)
Proceeds from divestitures, net of cash divested 46,002 155,728
Costs related to divestitures 0 (11,368)
Derivative settlements (203,238) (487,394)
Proceeds from sale of investment in unconsolidated affiliate 40,612 428,231
Distributions from investment in unconsolidated affiliate 8,499 40,607
Net cash used in investing activities (1,112,318) (325,699)
Cash flows from financing activities:    
Proceeds from revolving credit facilities 135,000 1,035,000
Principal payments on revolving credit facilities (135,000) (1,020,000)
Cash paid to settle Whiting debt 0 (2,154)
Deferred financing costs 0 (3,938)
Repurchases of common stock (157,122) (124,845)
Tax withholding on vesting of equity-based awards (13,823) (36,768)
Dividends paid (394,652) (500,106)
Payments on finance lease liabilities (1,398) (570)
Proceeds from warrants exercised 74,611 17,520
Net cash used in financing activities (492,384) (635,861)
Increase (decrease) in cash and cash equivalents (328,185) 484,074
Cash and cash equivalents:    
Beginning of period 593,151 174,783
End of period 264,966 658,857
Supplemental non-cash transactions:    
Change in accrued capital expenditures 77,091 41,348
Change in asset retirement obligations 1,057 412
Non-cash consideration exchanged in Merger 0 2,585,211
Investment in unconsolidated affiliate 0 568,312
Dividends payable $ 36,044 $ 27,256